🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 for elderly patients — swallowing and compliance advantages Page 5

Oral GLP-1 for elderly patients — swallowing and compliance advantages

GraceAZ_72 Sat, May 16, 2026 at 5:39 PM 31 replies 967 viewsPage 5 of 7
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
May 20, 2026 at 5:22 AM#21
julia.endo said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Adding the part of the answer the thread has not reached. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

19 17Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 16 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
May 21, 2026 at 12:44 AM#22

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

20 18DoseLogDan, SleepFixSam, PurityPaulOR and 17 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
May 21, 2026 at 8:06 PM#23

One thing that is still open after julia.endo’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: May 21, 2026 at 10:06 PM
21 19MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 18 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
May 22, 2026 at 3:27 PM#24
raj_cambridge said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

Last edited: May 22, 2026 at 7:27 PM
22 20MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 19 others
Reply Quote Save Share Report
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
May 23, 2026 at 10:48 AM#25
raj_cambridge said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

That is the short version; the long version is somebody else's post.

Last edited: May 23, 2026 at 3:48 PM
23 21NeuroNate, JessicaH_TX, KevinCompounds and 20 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register